Combined therapeutical treatment of hyperproliferative diseases
US7884082B2 · kind B2 · utility
0Cited by
7References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 14, 2003 |
| Grant date | Feb 8, 2011 |
| Priority date | — |
| Expiry date | Apr 22, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A medicinal combination of one or more nucleic acids that at least partially inhibit oncogenic cell signalling pathways, and a therapeutic anticancer agent, for use simultaneous, separate or over a period of time to treat hyperproliferative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.